Drug Controller General of India to pharma MNCs: Conduct fruitful clinical trials for Indians, D 10

NEW DELHI: Multinational pharmaceutical companies keen to conduct clinical trials for new drugs on Indians would have to ensure an early launch of those therapies in India if the trials result in commercial production, the drug regulator has said. In an order issued last week, the Drug Controller General of India (DCGI) said innovator drug firms would have to seek approval for such new drugs (

from CLINI INDIA http://ift.tt/VDn8GA

via IFTTT